Skip to main content

1 Result(s)

within Dong-yang Ding Remove this filter Biomedicine Remove this filter

and

  1. No Access

    Article

    Serum thrombospondin-1 serves as a novel biomarker and agonist of gemcitabine-based chemotherapy in intrahepatic cholangiocarcinoma

    At present, the first-line treatment for advanced intrahepatic cholangiocarcinoma (ICC) is gemcitabine combined with cisplatin, but a considerable portion of ICC patients exhibit resistance to gemcitabine. The...

    Dong-yang Ding, **ao-jie Gan, Jia-ning Zhang, Guo-jun Hou… in British Journal of Cancer (2023)